China Clinical Data Crackdown Sees Device-Makers Withdraw 101 Applications
Executive Summary
China FDA is now relentlessly clamping down on clinical data irregularities in the medtech industry, causing 51 manufacturers, including well-known multinational companies such as Boston Scientific and Olympus, to withdraw more than a hundred new device approvals filed with the agency.